These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6467036)

  • 1. Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons.
    Matthews RT; McMillen BA; Speciale SG; Jarrah H; Shore PA; Sanghera MK; Shepard PD; German DC
    Brain Res Bull; 1984 May; 12(5):479-86. PubMed ID: 6467036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On central muscle relaxants, strychnine-insensitive glycine receptors and two old drugs: zoxazolamine and HA-966.
    McMillen BA; Williams HL; Lehmann H; Shepard PD
    J Neural Transm Gen Sect; 1992; 89(1-2):11-25. PubMed ID: 1329854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of drug action in disease states. XXVII. Effect of experimental renal failure on the pharmacodynamics of zoxazolamine and chlorzoxazone.
    Yasuhara M; Levy G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):165-9. PubMed ID: 3260625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of nigrostriatal dopamine neurones by nicotine.
    Lichtensteiger W; Hefti F; Felix D; Huwyler T; Melamed E; Schlumpf M
    Neuropharmacology; 1982 Oct; 21(10):963-8. PubMed ID: 7145035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diazepam on behavior and dopamine-containing substantia nigra units in freely moving cats.
    Trulson ME
    Psychopharmacology (Berl); 1984; 84(1):91-5. PubMed ID: 6436896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds.
    Cao Y; Dreixler JC; Roizen JD; Roberts MT; Houamed KM
    J Pharmacol Exp Ther; 2001 Mar; 296(3):683-9. PubMed ID: 11181893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+-)-1-hydroxy-3-aminopyrrolidone-2 (HA-966) inhibits the activity of substantia nigra dopamine neurons through a non-N-methyl-D-aspartate receptor-mediated mechanism.
    Shepard PD; Lehmann H
    J Pharmacol Exp Ther; 1992 May; 261(2):387-94. PubMed ID: 1578355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transport and turnover of phospholipids in the rat nigrostriatal system: effects of d-amphetamine and haloperidol.
    Hitzemann R; Loh H
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):209-28. PubMed ID: 6122239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
    Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK
    Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
    Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
    Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA; Piercey MF
    J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats.
    Mereu G; Fadda F; Gessa GL
    Brain Res; 1984 Jan; 292(1):63-9. PubMed ID: 6697212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
    Melamed E; Durst R; Frucht Y; Globus M
    Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
    Santiago M; Westerink BH
    J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra.
    Nissbrandt H; Pileblad E; Carlsson A
    J Pharm Pharmacol; 1985 Dec; 37(12):884-9. PubMed ID: 2868096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
    Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
    Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in striatal dopamine activity following nigral muscimol infusions.
    Moshé SL; Sperber EF; Wurpel JN; Sharpless NS
    Brain Res; 1987 Jan; 428(1):129-32. PubMed ID: 3815107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.
    Matthews RT; Champney TH; Frye GD
    Pharmacol Biochem Behav; 1989 Aug; 33(4):741-7. PubMed ID: 2575758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of baclofen on striatal 5-HT mediated by the nigrostriatal dopamine system.
    Waldmeier PC; Feldtrauer JJ; Kam R; Stöcklin K
    Eur J Pharmacol; 1979 Mar; 54(3):279-87. PubMed ID: 428427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.